REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

Psych News Alert: FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer's Disease

FDA nod for Rexulti sNDA in treatment of Alzheimer's agitation

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Psychiatry Alzheimer's Diseasearticles page [1]

FDA advisors to weigh use of Rexulti for Alzheimer's agitation

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

agitation that may happen with dementia due to Alzheimer's disease Questionnaire

Pyrls on Instagram: Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation associated with dementia due to Alzheimer's disease ✨ Learn more about brexpiprazole in your Pyrls app or

FDA approves first drug to treat agitation associated with dementia due to Alzheimer's